CSA Medical has raised approximately $50.3 million in separate equity and debt rounds, according to recently posted SEC filings.
In its equity funding round, the Lexington, Mass.-based company raised approximately $45.2 million from 37 unnamed sources, with the first sale noted on January 25, 2019.
CSA Medical is still looking for $2.5 million in the round, which would bring the equity funding round to a total of $47.7 million, according to the SEC filing.
In its debt financing round, the company raised approximately $5.1 million from 39 unnamed sources, with the first date of sale noted as having occurred on December 21, 2017.
CSA Medical is not looking to raise any more funds in the debt financing round, according to the SEC filing.
The company has not yet stated how it plans to spend funds raised in either rounds.
Last October, CSA Medical said that it put a $23 million debt-and-equity round on ice for the cryospray technology it’s developing.